Efficacy and safety of ipragliflozin as an add-on to pioglitazone in Japanese patients with inadequately controlled type 2 diabetes : a randomized, double-blind, placebo-controlled study : the SPOTLIGHT study

Details 詳細情報について

• CRID

  1520291853568915200

• NII Article ID

  40020504756

• NII Book ID

  AA12503387

• ISSN

  21901678

• NDL BIB ID

  026549017

• Web Site

  http://id.ndl.go.jp/bib/026549017

  https://ndlsearch.ndl.go.jp/books/R000000004-I026549017

  https://search.jamas.or.jp/link/ui/2016091236

• Text Lang

  en

• NDL Source Classification

  • ZS21(科学技術--医学--内科学)

• Data Source

  • NDL
  • CiNii Articles